TY  - CONF
AU  - Blancas, I.
AU  - Rodriguez-Serrano, F.
PY  - 2020
DO  - 10.1016/j.annonc.2020.08.300
SN  - 0923-7534
UR  - https://hdl.handle.net/10668/26021
T2  - Annals of oncology
LA  - en
PB  - Elsevier
TI  - HER2/neu 655 A > G polymorphism is associated with higher cardiotoxicity but not with less efficacy of trastuzumab, in HER2-positive breast cancer patients
TY  - conference output
VL  - 31
ER  -